AcelRx phase III study of sublingual Sufentanil NanoTab PCA vs IV PCA morphine for post operative pain meets primary endpoint

AcelRx phase III study of sublingual Sufentanil NanoTab PCA vs IV PCA morphine for post operative pain meets primary endpoint

Submitted by admin on November 17, 2012 - 2:47pm
Source: 
Pharmabiz
News Tags: 
AcelRx
Sufentanil NanoTab PCA System
pain management
Headline: 
AcelRx phase III study of sublingual Sufentanil NanoTab PCA vs IV PCA morphine for post operative pain meets primary endpoint

Do Not Allow Advertisers to Use My Personal information